ConocoPhillips Makes Application to Cease to Be a Reporting Issuer in Canada
HOUSTON — ConocoPhillips (NYSE: COP) today announced that it has applied to the Alberta Securities Commission (ASC), as principal regulator, and the Ontario Securities Commission (OSC) for a joint order (the Order Sought) to cease to be a reporting issuer in all jurisdictions of Canada in which it is a reporting issuer. If the Order Sought is granted by the ASC and the OSC, ConocoPhillips will cease to be a reporting issuer in any jurisdiction in Canada.
Article content
Notwithstanding a decision that ConocoPhillips is not a reporting issuer in Canada, ConocoPhillips will continue to file all financial statements and other continuous disclosure materials required to be filed by it in accordance with the applicable securities laws of the United States and the rules of the New York Stock Exchange (NYSE). All such continuous disclosure documents of ConocoPhillips are publicly available to all security holders of ConocoPhillips under ConocoPhillips' profile at www.sec.gov. ConocoPhillips' security holders residing in Canada will continue to receive copies of the continuous disclosure documents that are required to be delivered to security holders in the United States, in the same manner and at the same time as is required under the applicable securities laws of the United States and the rules of the NYSE.
Article content
— # # # —
Article content
As a leading global exploration and production company, ConocoPhillips is uniquely equipped to deliver reliable, responsibly produced oil and gas. Our deep, durable and diverse portfolio is built to meet growing global energy demands. Together with our high-performing operations and continuously advancing technology, we are well positioned to deliver strong, consistent financial results, now and for decades to come. Visit us at www.conocophillips.com. FORWARD-LOOKING STATEMENTS This release contains forward-looking information that involves risks and uncertainties. Actual future results, including whether the Order Sought will be granted, could vary from those expressed or implied by the forward-looking information in this release, and depend on regulatory developments, including actions taken by the ASC, the OSC and/or other regulatory bodies. This forward-looking information is made as of the date of this release and, other than as required by applicable securities laws, ConocoPhillips does not assume any obligation to update or revise it to reflect new events or circumstances. The forward-looking information contained in this release is expressly qualified by this cautionary statement.
Article content
Article content
Article content
Contacts
Article content
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Globe and Mail
5 minutes ago
- Globe and Mail
US Bancorp (USB) Receives a Rating Update from a Top Analyst
RBC Capital analyst Gerard Cassidy maintained a Buy rating on US Bancorp yesterday and set a price target of $50.00. The company's shares closed yesterday at $45.21. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week. According to TipRanks, Cassidy is a top 25 analyst with an average return of 21.0% and a 71.60% success rate. Cassidy covers the Financial sector, focusing on stocks such as JPMorgan Chase, M&T Bank, and Morgan Stanley. In addition to RBC Capital, US Bancorp also received a Buy from Piper Sandler's Scott Siefers in a report issued today. However, on the same day, KBW maintained a Hold rating on US Bancorp (NYSE: USB). USB market cap is currently $71.17B and has a P/E ratio of 10.82. Based on the recent corporate insider activity of 39 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of USB in relation to earlier this year.
Globe and Mail
23 minutes ago
- Globe and Mail
Carney's ethics filing shows more than 100 entities under conflict-of-interest screen
Prime Minister Mark Carney must recuse himself from discussions, debates, decisions or votes specifically pertaining to more than 100 corporate entities, newly released ethics documents show. That includes Brookfield Asset Management Ltd., where he held a management role prior to entering politics, but also dozens of companies with ties to Brookfield, even if Mr. Carney personally has no role or direct financial interest. 'In all of his work for Canadians, the Prime Minister will continue to serve with the highest standards for integrity at all times,' spokesperson Audrey Champoux said in a statement. The filings were released Friday in compliance with a deadline under the Conflict of Interest Act requiring public disclosure within 120 days of Mr. Carney becoming Prime Minister in March. He had been pressed to make the information public ever since he launched his bid for leadership of the Liberal Party earlier this year. Carney promises conflict-of-interest screen to prevent him from making decisions for companies he served Mr. Carney came to federal politics after a high-profile career in the private sector, including a stint as board chair for Brookfield Asset Management Ltd., a US$1-trillion asset manager whose investments touch on numerous sectors. Mr. Carney's critics had argued that his connections to the company potentially placed him in a conflict of interest − as Prime Minister, his decisions might not just benefit Brookfield, but also Mr. Carney personally through his own financial relationship with the company. Mr. Carney resigned from his board positions at the start of his leadership campaign, saying if he won he'd begin the process of compliance with ethics law. During the subsequent federal election, he said he had set up ethics screens and put his assets in a trust. But, he resisted calls to publicly disclose the scope of those screens or his holdings ahead of the legally required deadline. As a public office holder, he must report assets, liabilities, income and activities to the Conflict of Interest and Ethics Commissioner, and then a statement of those holdings must be made public within 120 days. Conflict-of-interest screens can in turn be proposed by the Ethics Commissioner as a preventive measure. The screen means he can't be aware of or participate in any matters specifically involving the companies' interests, but may participate in discussions or decisions that are general in nature or could affect the companies' interests more broadly. Mr. Carney was also required to divest of any assets that could be directly or indirectly affected by government decisions or policy. He opted to place them in a blind trust. That means he no longer has control over how the holdings are managed. Though the financial value of his holdings is disclosed to the Ethics Commissioner, that number is not made public. In addition to his roles with Brookfield, he was a director of the board of payments processor Stripe Inc. and an advisory board for investment giant PIMCO, among other private-sector jobs. The disclosures list hundreds of individual stocks held through an investment account. They include many stocks found in a typical mutual fund or index fund sold to ordinary investors, such as Walmart, Starbucks, video conferencing company Zoom, and tech giants such as Microsoft and That investment account does not include many of the largest Canadian companies, including those in highly regulated industries, such as major Canadian banks, telecommunications companies or energy producers. Mr. Carney also continues to own an interest in Brookfield Asset Management Ltd. He owns stock options and deferred share units in Brookfield and its parent company, Brookfield Corp., worth millions of dollars at current share prices, though their value fluctuates as Brookfield's stock rises or falls. The disclosures reveal that he owns shares of Partners Value Investments LP, a fund through which Brookfield's most senior executives own a large block of Brookfield shares. Those shares are typically only awarded to an exclusive group of Brookfield insiders, demonstrating the prominent position he held at the company. The Prime Minister is eligible to take part in the 'notional long-term inventive plan' for the Brookfield Global Transition Fund, a US$15-billion pool of capital that Mr. Carney spearheaded that makes large investments in technologies such as carbon capture and storage, solar power and batteries, and nuclear services. Mr. Carney could earn bonuses if it performs well. It is not clear if those incentives would be paid in cash, stock, or in carried interest − a cut of the fund's profits after it meets a certain threshold for investment gains. Mr. Carney divided his conflict screen into three sections. One is companies where he had a management position or an oversight role. The second lists Brookfield portfolio companies in the Registry of Lobbyists. The third section is described in the records as 'entities being screened out of an abundance of caution,' identified by the Ethics Commissioner as being Brookfield-related, 'even though I had no role in managing them, and no direct financial interest in them.' The screen is administered by his chief of staff and by the Clerk of the Privy Council. Even before the records were public, Mr. Carney was obligated to recuse himself from decisions that could place him in a conflict of interest. Those recusals must be made public within 60 days. None are listed on the Ethics Commissioner's website. A spokesperson for the opposition Conservatives said Friday that they were not officially commenting until they had a chance to fully review the records.
Globe and Mail
an hour ago
- Globe and Mail
All It Takes Is $2,000 Invested in Each of These High Dividend Stocks to Help Generate Over $280 in Passive Income Per Year
Key Points Income-focused investors seeking reliable dividends and a stable company can consider investing in telecommunications giant Verizon. AT&T's disciplined financial management is supporting its solid 4.1% dividend yield. AbbVie's ability to thrive post-Humira, combined with a 53-year history of dividend growth, makes it a smart buy now. 10 stocks we like better than Verizon Communications › It has been a volatile year for the U.S. markets, with many stocks experiencing impressive highs and sharp lows. Investing in such a turbulent environment may feel daunting for retail investors. However, dividend-paying stocks can help generate substantial passive income even amid market fluctuations. With the correct picks, investors can generate a steady dividend income even with a relatively modest investment. For instance, investing $2,000 each in Verizon Communications (NYSE: VZ), AT&T (NYSE: T), and AbbVie (NYSE: ABBV) will generate a total of $282.60 in passive income annually. Here's how the dividend income breaks down: With a 6.5% yield, $2,000 invested in Verizon will generate $130.20 in annual dividends. With a 4.1% yield, $2,000 invested in AT&T will generate $82.40 in annual dividends. With a 3.5% yield, $2,000 invested in AbbVie will generate $70 in annual dividends. These stocks are not only reliable dividend payers, but also boast strong business models and a rich and durable history of returning value to shareholders. Verizon Communications giant Verizon offers investors a sustainable 6.5% dividend yield, which translates to $2.71 annually per share, all backed by solid business fundamentals. It has raised its dividend for 18 consecutive years. Verizon's strong financial results underline the stability of its dividend policy. The company delivered its highest-ever quarterly adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) of $12.6 billion in the first quarter of fiscal 2025 (ending March 31). Free cash flow was $3.6 billion. With a dividend payout ratio of 64.2%, there are enough earnings to cover the dividend. The company's convergence strategy, which integrates its wireless and wireline networks (including 5G and fiber-optic networks) to create comprehensive connectivity solutions, has proven successful. This has helped reduce customer churn by 40% to 50% for both mobility and fiber products. A sticky customer base translates into predictable cash flows. Besides retaining existing customers, the company is also rapidly acquiring new clients. Verizon added 339,000 broadband customers and 308,000 fixed wireless customers in the first quarter. The company aims to achieve a goal of 100 million premises with fiber and fixed wireless access following the completion of its pending Frontier acquisition. Besides telecommunication services, Verizon built a robust adjacent services business (including discounted streaming services and other subscriptions, insurance products, and financial services) expected to clock an annual run rate of $2 billion by the end of 2025. The business also boasts mid-30s margins. Management is guiding for 2% to 3.5% adjusted EBITDA growth and free cash flows of $17.5 billion to $18.5 billion in 2025. This provides the required cushion for dividend sustainability. Hence, for investors seeking to earn passive income from high-quality companies, Verizon appears to be a smart buy now. AT&T Telecommunications giant AT&T is offering a solid 4.1% yield, which translates to $1.11 per share annually. The dividend also appears well-covered with a 68.1% dividend payout ratio, implying that the company also has the flexibility to increase dividends in the coming years. AT&T expects to resume share buybacks in the second quarter of fiscal 2025 as part of a $10 billion repurchase program, with at least $3 billion completed by the end of fiscal 2025, and the remainder allocated for fiscal 2026. AT&T has also been increasingly focusing on financial discipline. Since 2020, the company reduced its net debt by $32 billion. It ended the first quarter of fiscal 2025 with a net debt-to-adjusted EBITDA ratio of 2.63, lower than the 2.68 ratio at the end of fiscal 2024. In Q1, the company's revenues increased 2% to $30.6 billion, net income rose 23.6% year over year to $4.7 billion, and free cash flow increased 10.7% year over year to $3.1 billion. These numbers demonstrate AT&T's ability to fund its dividend policy sustainably while maintaining sufficient financial flexibility to invest in growth initiatives and repurchase shares. AT&T also has exceptional fiber and wireless businesses, both of which are relatively recession-resistant. The company is currently operating the largest fiber network in the U.S. and expects to hit 30 million fiber locations by mid-2025 and 50 million by 2029. This expansion is already driving strong customer growth, with 261,000 fiber net additions in Q1 alone. Additionally, the company's wireless network modernization and fixed wireless expansion contributed to a customer count increase of 181,000 during Q1. AT&T is also benefiting by bundling its services, creating stickier and more profitable customer relationships. AT&T Fiber and wireless services have 15% higher lifetime values than stand-alone customers. For income investors seeking defensive dividend growth, this transformed telecommunications player is an appealing pick now. AbbVie AbbVie also offers an impressive yield of 3.52% with an annual payout of $6.56 per share. With its history of increasing dividends for 53 consecutive years (including its Abbott Laboratories heritage), AbbVie sports the prestigious Dividend King status. When AbbVie lost the patent protection for its blockbuster immunology drug Humira in 2023, many investors were concerned about the sustainability of its dividend policy. However, the company has successfully reduced its over-reliance on Humira and continues to thrive even after the dreaded patent cliff. Humira's sales have fallen more than expected, decreasing by 49.5% year over year to $1.1 billion in Q1 of fiscal 2025. However, its next-generation immunology drugs Skyrizi and Rinvoq are showing impressive results, generating a combined $5.1 billion, a substantial 65% year-over-year increase. Management now expects these two drugs to generate $31 billion in combined sales by 2027, surpassing Humira's peak sales of $20.7 billion. In addition to immunology, AbbVie has successfully diversified into areas such as neuroscience, oncology, and aesthetics. The company is also focusing on strategic investments, including a $350 million obesity partnership with Gubra and plans for a $2.1 billion acquisition of CAR-T therapy developer Capstan Therapeutics. These deals will position AbbVie in several high-growth areas. Recently, however, AbbVie announced that the acquired in-process research and development (IPR&D) and milestone expenses have negatively affected its second-quarter earnings guidance. While these represent a short-term challenge, the deals can prove to be major growth drivers in the long run. With AbbVie proving its capability to navigate major patent cliffs while growing its dividend, I think the stock is worth considering in 2025. Should you invest $1,000 in Verizon Communications right now? Before you buy stock in Verizon Communications, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Verizon Communications wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $687,149!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,060,406!* Now, it's worth noting Stock Advisor's total average return is 1,069% — a market-crushing outperformance compared to 180% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of July 15, 2025
